Loading…
for educational and safety purposes
Duloxetine and Venlafaxine both come up in the same conversations; they overlap on Mood. Duloxetine: Duloxetine is a balanced serotonin-norepinephrine reuptake inhibitor, marketed chiefly as Cymbalta since 2004, approved for major depression and generalized anxiety as well as several chronic pain conditions. Venlafaxine: Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used for major depressive disorder and several anxiety disorders, and available in immediate-release and extended-release forms.
Duloxetine is a balanced serotonin-norepinephrine reuptake inhibitor, marketed chiefly as Cymbalta since 2004, approved for major depression and generalized anxiety as well as several chronic pain conditions. Its analgesic action reflects potentiation of descending serotonergic and noradrenergic pathways that dampen pain signaling in the spinal cord, an effect largely separate from its antidepressant activity. Randomized trials support its use in diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain from osteoarthritis and low back pain, and it is the agent with the strongest randomized evidence recommended by oncology guidelines for chemotherapy-induced peripheral neuropathy. Through the same monoaminergic facilitation of pudendal motor neurons in Onuf's nucleus, duloxetine strengthens urethral sphincter tone and is used in some countries for stress urinary incontinence. It is a prescription-only medicine, available generically, and appears on the World Health Organization list of essential medicines.
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used for major depressive disorder and several anxiety disorders, and available in immediate-release and extended-release forms. It is distinguished by an ascending dose-response relationship: at low doses it behaves much like a selective serotonin reuptake inhibitor, while progressively higher doses recruit norepinephrine reuptake inhibition, which contributes both to added efficacy and to dose-dependent increases in blood pressure. Beyond monoamine transport, preclinical work implicates sigma-1 receptor modulation in its antidepressant action, and the drug is widely repurposed as an effective nonhormonal treatment for menopausal and cancer-therapy-related hot flashes. Network meta-analyses place it among the more efficacious antidepressants, although tolerability, cardiovascular effects in overdose, and a pronounced discontinuation syndrome temper its use.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
inhibits
inhibits
inhibits
inhibits
inhibits
inhibits
modulates
modulates
modulates
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.